158 related articles for article (PubMed ID: 1503094)
1. Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia.
Smalley RV; Connors J; Tuttle RL; Anderson S; Robinson W; Whisnant JK
Am J Hematol; 1992 Sep; 41(1):13-8. PubMed ID: 1503094
[TBL] [Abstract][Full Text] [Related]
2. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
3. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group.
Smalley RV; Anderson SA; Tuttle RL; Connors J; Thurmond LM; Huang A; Castle K; Magers C; Whisnant JK
Blood; 1991 Dec; 78(12):3133-41. PubMed ID: 1742480
[TBL] [Abstract][Full Text] [Related]
6. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
Shibata T; Hotta T
Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
[TBL] [Abstract][Full Text] [Related]
7. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
8. Hairy cell leukaemia: the role of alpha interferon.
Platanias LC; Ratain MJ
Eur J Cancer; 1991; 27 Suppl 4():S53-7. PubMed ID: 1799481
[TBL] [Abstract][Full Text] [Related]
9. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
Troussard X; Flandrin G
Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
[TBL] [Abstract][Full Text] [Related]
10. Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
Capnist G; Federico M; Chisesi T; Resegotti L; Pagnucco G; Castoldi GL; Lamparelli T; Frassoldati A; Guarnaccia C; Leoni P
Leuk Res; 1991; 15(6):419-26. PubMed ID: 1861528
[TBL] [Abstract][Full Text] [Related]
11. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy.
Ratain MJ; Vardiman JW; Barker CM; Golomb HM
Cancer; 1988 Dec; 62(11):2420-4. PubMed ID: 3179961
[TBL] [Abstract][Full Text] [Related]
12. Interferon in the treatment of hairy-cell leukemia.
Ahmed S; Rai KR
Best Pract Res Clin Haematol; 2003 Mar; 16(1):69-81. PubMed ID: 12670466
[TBL] [Abstract][Full Text] [Related]
13. The role of interferon in the treatment of hairy cell leukemia.
Ratain MJ; Vardiman JW; Golomb HM
Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
[TBL] [Abstract][Full Text] [Related]
14. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
Golomb HM; Jacobs A; Fefer A; Ozer H; Thompson J; Portlock C; Ratain M; Golde D; Vardiman J; Burke JS
J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
[TBL] [Abstract][Full Text] [Related]
15. Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis.
Damasio EE; Clavio M; Masoudi B; Isaza A; Spriano M; Rossi E; Casciaro S; Cerri R; Risso M; Nati S; Siccardi M; Truini M; Gobbi M
Eur J Haematol; 2000 Jan; 64(1):47-52. PubMed ID: 10680705
[TBL] [Abstract][Full Text] [Related]
16. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
[TBL] [Abstract][Full Text] [Related]
20. Hairy cell leukemia. Current management.
Doane LL; Ratain MJ; Golomb HM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):489-502. PubMed ID: 2182604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
